Viewing Study NCT00502567


Ignite Creation Date: 2025-12-25 @ 12:27 AM
Ignite Modification Date: 2026-01-05 @ 5:47 PM
Study NCT ID: NCT00502567
Status: COMPLETED
Last Update Posted: 2011-07-27
First Post: 2007-07-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Assess Safety, Tolerability and PK of AZD2171 and Chemotherapy on Patients With Solid Tumors
Sponsor: AstraZeneca
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Advanced Solid Tumor View
Keywords:

Keywords

Keyword Brief Keyword Text View
None advanced solid tumors View
None AZD2171 View
None Phase I View